​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $106.00, with a high of $115.00 and a low of $97.00. This represents a 168.90% increase from the last price of $39.42.

$20 $39 $58 $77 $96 $115 High: $115 Avg: $106 Low: $97 Last Closed Price: $39.42

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (75.00%), 2 Hold (16.67%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 2 9 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines168.90%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$115.00$95.83
Last Closing Price$39.42$39.42$39.42
Upside/Downside-191.73%143.10%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2538-1-12
Aug, 2538-1-12
Jul, 2538-1-12
Jun, 2538-1-12
May, 2537-1-11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 05, 2025H.C. Wainwright$115.00$47.79140.64%191.73%
Jun 02, 2025Jay OlsonOppenheimer$97.00$39.82143.60%146.07%
Mar 03, 2025Truist Financial$85.00$33.55153.35%115.63%
Mar 03, 2025Guggenheim$120.00$33.55257.68%204.41%
Mar 03, 2025Needham$85.00$33.55153.35%115.63%
Mar 03, 2025Robert W. Baird$73.00$33.55117.59%85.19%
Sep 04, 2024Douglas TsaoH.C. Wainwright$60.30$29.25106.15%52.97%
Sep 04, 2024Ami FadiaNeedham$75.90$29.25159.49%92.54%
Sep 03, 2024Francois BriseboisOppenheimer$71.85$27.83158.17%82.27%
Sep 03, 2024Joon LeeTruist Financial$75.38$27.08178.36%91.22%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2025JefferiesBuyBuyhold
Aug 05, 2025H.C. WainwrightBuyBuyhold
Mar 03, 2025Deutsche BankBuyBuyhold
Feb 28, 2025WedbushBuyUnderperformdowngrade
Feb 28, 2025H.C. WainwrightBuyBuyhold
Oct 14, 2024OppenheimerOutperformOutperformhold
Sep 24, 2024Cowen & Co.BuyBuyhold
Sep 04, 2024Piper SandlerUnderperformUnderperformhold
Sep 04, 2024NeedhamBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21----
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M----
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%----

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 12 Wall Street analysts, averages $106 over the next 12 months. The price target range spans from $97 at the low end to $115 at the high end, suggesting a potential 168.90% change from the previous closing price of $39.42.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 168.90% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • September 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 8.33% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 8.33% Sell, 0% Strong Sell.
  • July 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 8.33% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2025 is $-11.47, marking a 12.34% increase from the reported $-10.21 in 2024. Estimates for the following years are $-11.46 in 2026, $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2025 is $967.3K, reflecting a -88.69% decrease from the reported $8.55M in 2024. The forecast for 2026 is $31.98M, followed by $101.46M for 2027, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2025 stands at $-75.239M, representing a -58.84% decrease from the reported $-183M in 2024. Projections indicate $-85.528M in 2026, $-66.138M in 2027, and $-15.629M in 2028.